Atria Investments’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$265K Sell
6,629
-3,023
-31% -$143K ﹤0.01% 1825
2025
Q4
$434K Buy
9,652
+1,037
+12% +$48K ﹤0.01% 1533
2025
Q3
$385K Buy
8,615
+941
+12% +$45K ﹤0.01% 1579
2025
Q2
$369K Buy
7,674
+218
+3% +$9.48K ﹤0.01% 1592
2025
Q1
$299K Buy
7,456
+183
+3% +$7.7K ﹤0.01% 1625
2024
Q4
$333K Sell
7,273
-147
-2% -$6.58K ﹤0.01% 1548
2024
Q3
$348K Buy
7,420
+421
+6% +$19.2K ﹤0.01% 1533
2024
Q2
$296K Buy
+6,999
New +$307K ﹤0.01% 1593

Other funds holding QGEN

Atria Investments's QGEN Position: Q1 2026 in Review

Atria Investments reduced its Qiagen (QGEN) stake by 31% in Q1 2026, selling an estimated $143K and leaving 6,629 shares worth $265K. The position accounts for ﹤0.01% of the portfolio, ranked #1825.

Atria Investments first reported a position in QGEN in Q2 2024 and has held it in 8 quarters since. The position peaked at $434K in Q4 2025. 343 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

  • Atria Investments held 6,629 shares of Qiagen worth $265K as of Q1 2026.
  • Atria Investments sold 3,023 Qiagen shares in Q1 2026, an estimated $143K.
  • Qiagen made up ﹤0.01% of Atria Investments's portfolio in Q1 2026, its #1825 holding.
  • Atria Investments first reported a position in Qiagen in Q2 2024 and has held it in 8 quarters since.
  • Atria Investments's Qiagen position peaked at $434K in Q4 2025.
  • 343 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.